OrphaDRGL: A Novel Graph Deep Learning-based Drug Repositioning Approach for Orphan Diseases
ISEF · 2021 Computational Biology and Bioinformatics Second Award
Overview
More than 95% of the approximately 7000 orphan diseases in the world do not have effective treatments, and since orphan diseases are conditions that affect a limited population, there is little incentive to develop novel treatments for them. Thus, drug repositioning, or finding new uses for existing drugs, has become a viable option as it is faster and more economical than traditional de novo drug discovery. To this end, OrphaDRGL was created: a novel computational orphan disease drug repositioning approach utilizing graph deep learning. OrphaDRGL uses open-source disease phenotype, drug side effect, drug chemical structure, and drug-indication data to form a heterogenous network with drug and medical condition nodes. Edges were created using the Tanimoto coefficient of drug side effects and chemical structures, Resnik phenotypic similarity of medical conditions and their phenotypes, and existing drug-indication pairs. Morgan fingerprint bit vectors were assigned as explicit node features for drug nodes. A link concealing algorithm was then applied to emulate orphan disease conditions, and a graph convolutional neural network-based link prediction framework was trained on the network in order to identify potential drug repositioning candidates for orphan diseases. After 10-fold cross-validation, OrphaDRGL achieved an average AUC-ROC score of 0.953. In addition, OrphaDRGL was able to identify both literature-supported and previously unreported drug repositioning candidates for three different orphan diseases. OrphaDRGL is the first of its kind in the scientific literature, and its promising performance helps address the pressing issue of in silico identification of potential drug repositioning candidates for orphan diseases.
Awards (1)
- Second Award of $2,000 $2,000
Competition history
- ISEF 2021
Resources
Related projects
ISEF · 2021
A Novel Computational Approach to Drug Discovery Through Drug Repositioning
ISEF · 2024
GraphChem: A Soft Graph Mixture of Experts Based Adversarial Variational Spectral Graph Autoencoder for De Novo Drug Design & Other Pharmacological Objectives
ISEF · 2022
Novel-DTI: A Machine Learning Pipeline To Predict Drug-Target Interactions for Large-Scale Drug Repurposing and Drug Discovery Using Multiplex, Heterogeneous Networks
ISEF · 2022
Using Artificial Intelligence Graph Neural Networks To Repurpose Pre-existing Drugs and Analyze Drug Relationships: Year 2
Closest projects by meaning, across every fair and year in the corpus.
Source: Regeneron International Science and Engineering Fair